Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1565 of 5804
-
Faricimab passes Long-Term safety check in wet AMD patients
Disease control CompletedThis main long-term extension study is designed to evaluate the long-term safety and tolerability of faricimab 6 milligrams (mg) administered by intravitreal injection at a personalized treatment interval (PTI) to participants with neovascular age-related macular degeneration (nA…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood filtering shows promise for severe COVID-19 patients
Disease control CompletedSevere Covid-19 (Coronavirus Disease 2019) infections generate major but inappropriate production of cytokines and, in some cases, generate anti-IFN (Interferon) auto-antibodies, inducing acute respiratory distress syndrom (ARDS). Therapeutic plasma exchange (TPE) have been repor…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 13:04 UTC
-
Smart wearable alerts aim to cut heart failure hospitalizations
Disease control CompletedHeart failure (HF) is a type of heart disease that leads to need of admissions to the hospital during worsening of symptoms. These admissions are expensive and very inconvenient for patients. The investigators have previously shown that monitoring of patients with a using a small…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Higher doses of SMA drug tested for Long-Term safety
Disease control OngoingIn this study, researchers will learn more about the use of nusinersen (BIIB058) in participants with spinal muscular atrophy (SMA). This study is an extension study and will enroll only those participants who have completed treatment in the parent study, 232SM203. The main goal…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Talking therapy shows promise for autism Self-Harm
Symptom relief CompletedDialectical Behavior Therapy (DBT; Linehan, 1993) effectively diminishes emotion dysregulation and self-harm behaviors in a number of disorders. However, to our knowledge, no studies have investigated the efficacy of DBT to treat emotional dysregulation associated with self-harm …
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Brain Wave-Guided nerve stimulation may tame Drug-Resistant epilepsy
Disease control OngoingVagal nerve stimulation (VNS) is one of the neuromodulation techniques that can be indicated in patients suffering from refractory epilepsies, especially when an open resection has failed or is not indicated. However to date it is not possible to predict which patients will respo…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can DNA glitches predict prostate cancer treatment success?
Knowledge-focused Recruiting nowThis study investigates how well radium-223 works in treating patients with castration-resistant prostate cancer than has spread to the bones (bone metastases). Prostate cancer is the most common cancer in men and the second leading cause of cancer death. Furthermore, many men wi…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can physiotherapy boost brain implant benefits for Parkinson's patients?
Disease control OngoingDeep brain stimulation (DBS) is the most commonly performed surgical treatment for individuals with Parkinson's disease (PD). DBS typically works best to lessen motor symptoms such as stiffness, slowness, and tremor. Despite an overall improvement of these motor symptoms with DBS…
Phase: NA • Sponsor: University of Toronto • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New couples therapy aims to curb veteran suicide
Disease control CompletedSuicide prevention is the top clinical priority for VA/DoD. Suicide is one of the leading causes of death in the United States and worldwide with suicide rates among U.S. military Veterans doubling (27.7 per 100,000) the rate of civilian levels. Despite a rise in prevention effor…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Wisconsin tribe tests coaching to slash stroke risk
Prevention CompletedThis project will develop a "Stroke Awareness Team" including training of Oneida Health Service Coaches working in partnership with the UW team for a population-based health awareness program. This team will develop a series of Oneida Nation Healthy Living and Stroke Awareness Ev…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
Could a quicker dose Ramp-Up make CLL treatment easier?
Disease control OngoingThis research study is trying to determine which patients with newly diagnosed or relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), as grouped by their risk for tumor lysis syndrome (TLS), are able to safely tolerate an accelerated, daily…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for AL amyloidosis patients who failed first-line therapy
Disease control OngoingThis study will test the hypothesis that in patients with previous daratumumab exposure, combination therapy of daratumumab, pomalidomide, and dexamethasone (DPd) will yield higher complete remission (CR) rates in relapsed/refractory amyloidosis than historical pomalidomide/dexam…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Heart surgery patients may get kidney protection from old iron drug
Prevention OngoingMultiple lines of evidence support a central role of iron in causing acute kidney injury (AKI), including the finding that prophylactic administration of iron chelators attenuates AKI in animal models. Patients undergoing cardiac surgery may be particularly susceptible to iron-me…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New balloon treatment for blocked leg arteries put to the test
Disease control OngoingThis study is a prospective, interventional, multi-center 1:1 randomized non-inferiority trial. The trial evaluates the safety and efficacy of the Magic Touch PTA sirolimus drug-coated balloon in comparison to the treatment with PTX drug-coated balloon (control device) in patien…
Phase: NA • Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for kids with arthritis: drug trial shows promise
Disease control OngoingThe reason for this study is to see if the study drug ixekizumab is safe and effective in children with juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) (including juvenile onset ankylosing spondylitis \[JoAS\]) and juvenile psoriatic arthritis…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Sleep apnea treatment may be key to stopping diabetes in prediabetes
Prevention OngoingDespite the efficacy of intensive lifestyle interventions in prediabetes, the incidence of diabetes is rising, and thus there is a critical need for additional strategies to prevent diabetes and to reduce its cardiovascular complications in this high-risk population. Sleep apnea …
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Blue blood wash may ease Post-Heart surgery complications
Disease control CompletedIntroduction: Fluid overload and systemic inflammation are major contributors to postoperative complications in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Objective: To evaluate the effects of blood washing with methylene blue during zero-balance ultra…
Phase: PHASE2 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New antibody aims to unlock immune attack on Hard-to-Treat cancers
Disease control CompletedAn open-label, dose-escalation, phase I clinical study to evaluate the safety and tolerability of JS004 injection in the patients with advanced solid tumors who have failure in standard of care and are unable to tolerate standard of care and/or have no available standard of care.…
Phase: PHASE1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Contrast-Enhanced mammography: sharper images to catch hidden breast cancers?
Diagnosis OngoingThis clinical trial examines a new imaging technology, contrast-enhanced mammography, in predicting breast cancer. Contrast-enhanced mammography is similar to standard mammography, but it includes an intravenous (by vein) injection of iodine-based contrast, which makes tissue and…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Fasting fix? new study tests 4-Week diet to boost insulin in prediabetes and diabetes
Disease control Recruiting nowType 2 diabetes (T2D) mellitus is a challenge for health care systems as the numbers increases constantly. In 2014, 422 million people had been living with diabetes worldwide. The absolute numbers of people with prediabetes have also grown substantially over 25 years worldwide. I…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC